December 16, 2021 — MVP Health Care and The University of Vermont Health Network recently announced their joint Medicare Advantage Plan, called UVM Health Advantage, will offer older adults in Northern New York and Vermont support for their two biggest health concerns: heart disease and diabetes.

A large-scale NIH genetic testing study of people from diverse ancestries, researchers narrowed down the number of genomic variants that are strongly associated with blood lipid levels and generated a polygenic cardiovascular risk score to predict elevated low-density lipoprotein cholesterol levels. Getty Images

In a large-scale study of people from diverse ancestries, researchers narrowed down the number of genomic variants that are strongly associated with blood lipid levels and generated a polygenic risk score to predict elevated low-density lipoprotein cholesterol levels, a major risk factor for heart disease. The study, published in the journal Nature,[1] was led by the Global Lipids Genetics Consortium.

December 16, 2021 – Spanish pharmaceutical company Ferrer and the Spanish National Center for Cardiovascular Research (Centro Nacional de Investigaciones Cardiovasculares — CNIC), announced the results of NEPTUNO, the first real-world clinical study on patients treated with the CNIC-Polypill. This single pill, composed of the three class A medications recommended in the cardiovascular prevention guidelines,[1] is used to treat patients who have previously suffered a cardiovascular (CV) event, such as heart-attack or ischemic stroke.
 

December 16, 2021 — Datascope/Getinge/Maquet has recalled the Cardiosave Hybrid and Cardiosave Rescue Intra-Aortic Balloon Pump (IABP) systems because of one death and 71 complaints reported about  fluid leaks. Fluid entering the Cardiosave IABP may cause unexpected pump shutdown or the inability to initiate therapy.

December 15, 2021 — As COVID-19 variants continue to spread and individuals struggle with lingering effects long after the initial infection, the American Heart Association (AHA) has announced a $10 million research initiative to fund new studies into the long-term effects of the coronavirus and its impact on the cardiovascular and cerebrovascular systems. 

December 15, 2021 — Conavi Medical Inc. has entered into agreements for over $20 million in funding to support commercialization and growth as it prepares its innovative Novasight Hybrid System for market. The company aims to raise an additional $10 million as part of an ongoing financing effort.  

DAIC maintains a comprehensive listing of cardiology specialty meetings on its website at www.dicardiology.com/events. Find the dates, location and links to cardiology conferences in one location.

Radiological Society of North American (RSNA)

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now